Baker Brothers Life Sciences LP (CIK 1363364) reported 110 SEC Form 4 insider transactions across 11 companies over the past 18 months (most recent 2026-09-16). Recent activity: Buy ONC (30,768 shares), Buy ONC (30,768 shares), Buy INCY (400 shares), Buy INCY (400 shares), Buy MDGL (908 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | BeOne Medicines Ltd. (ONC) | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BeOne Medicines Ltd. (ONC) | Director | Buy | 30,768 | $1.1M |
| 2026-07-02 | INCYTE CORP (INCY) | Director | Buy | 400 | $0 |
| 2026-07-02 | INCYTE CORP (INCY) | Director | Buy | 400 | $0 |
| 2026-06-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 908 | $0 |
| 2026-06-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 908 | $0 |
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | Director | Buy | 18,980 | $0 |
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | Director | Buy | 18,980 | $0 |
| 2026-06-10 | INCYTE CORP (INCY) | Director | Buy | 1,642 | $0 |
| 2026-06-10 | INCYTE CORP (INCY) | Director | Buy | 1,642 | $0 |
| 2026-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,408 | $0 |
| 2026-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,408 | $0 |
| 2026-06-02 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 6,078 | $0 |
| 2026-06-02 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 6,078 | $0 |
| 2026-06-02 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 18,622 | $0 |
| 2026-06-02 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 18,622 | $0 |
| 2026-05-27 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,743 | $65,421 |
| 2026-05-27 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,743 | $65,421 |
| 2026-05-27 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,756 | $65,565 |
| 2026-05-27 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,756 | $65,565 |
| 2026-05-11 | INCYTE CORP (INCY) | Director | Buy | 15,000 | $1.3M |
| 2026-05-11 | INCYTE CORP (INCY) | Director | Buy | 15,000 | $1.3M |
| 2026-04-02 | INCYTE CORP (INCY) | Director | Buy | 421 | $0 |
| 2026-04-02 | INCYTE CORP (INCY) | Director | Buy | 421 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Director | Buy | 19,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16